Advertisement

ADVERTISEMENT

Riya Gandhi, MA, Associate Editor

acne
News
Ceramide-Containing Skin Care in Acne Management
11/19/2023
Riya Gandhi, MA, Associate Editor
A recent review published in the Journal of Cosmetic Dermatology explores the often-overlooked relationship between acne and the skin's protective barrier function and the ways in which optimizing skin care regimens can play a pivotal role in...
A recent review published in the Journal of Cosmetic Dermatology explores the often-overlooked relationship between acne and the skin's protective barrier function and the ways in which optimizing skin care regimens can play a pivotal role in...
A recent review published in the...
11/19/2023
The Dermatologist
Atopic dermatitis
News
Cardiovascular and Thromboembolism Risks in Patients With Atopic Dermatitis
11/18/2023
Riya Gandhi, MA, Associate Editor
A comprehensive cohort study has uncovered compelling evidence suggesting that AD may significantly heighten the risk of atherothrombotic and cardiovascular disease, as well as venous thromboembolism.
A comprehensive cohort study has uncovered compelling evidence suggesting that AD may significantly heighten the risk of atherothrombotic and cardiovascular disease, as well as venous thromboembolism.
A comprehensive cohort study has...
11/18/2023
The Dermatologist
Photopneumatic
News
Photopneumatic Technology Offers Promising Alternative for Acne Treatment
11/13/2023
Riya Gandhi, MA, Associate Editor
A recent study published in the Journal of Clinical and Aesthetic Dermatology suggests that the TheraClearX System is a promising and effective option for treating a broad spectrum of acne conditions, potentially offering relief to many...
A recent study published in the Journal of Clinical and Aesthetic Dermatology suggests that the TheraClearX System is a promising and effective option for treating a broad spectrum of acne conditions, potentially offering relief to many...
A recent study published in the...
11/13/2023
The Dermatologist
Atopic dermatitis
News
The Complexities of Atopic Dermatitis Severity
11/10/2023
Riya Gandhi, MA, Associate Editor
A recent study conducted by the Atopic Dermatitis Research Network aimed to identify the historical, clinical, and biomarker determinants associated with the severity of atopic dermatitis.
A recent study conducted by the Atopic Dermatitis Research Network aimed to identify the historical, clinical, and biomarker determinants associated with the severity of atopic dermatitis.
A recent study conducted by the...
11/10/2023
The Dermatologist
Acne
News
Laser a Safe Alternative for Treating Acne
11/04/2023
Riya Gandhi, MA, Associate Editor
A recent study published in the Journal of Cosmetic Dermatology sheds light on an exciting development in the treatment of acne. A 1726 nm laser may offer a safe and highly effective alternative to traditional acne therapies.
A recent study published in the Journal of Cosmetic Dermatology sheds light on an exciting development in the treatment of acne. A 1726 nm laser may offer a safe and highly effective alternative to traditional acne therapies.
A recent study published in the...
11/04/2023
The Dermatologist
Atopic Dermatitis + Baby + Face
News
Infant Atopic Dermatitis Treatment Reduces Food Allergy Risk
10/17/2023
Riya Gandhi, MA, Associate Editor
A recent study published in the Journal of Allergy and Clinical Immunology discovered that enhanced early skin treatment can substantially reduce the risk of developing food allergies in infants with atopic dermatitis.
A recent study published in the Journal of Allergy and Clinical Immunology discovered that enhanced early skin treatment can substantially reduce the risk of developing food allergies in infants with atopic dermatitis.
A recent study published in the...
10/17/2023
The Dermatologist
psoriasis
News
Patients With Plaque Psoriasis See Long-Term Quality of Life Improvements With Certolizumab Pegol
10/12/2023
Riya Gandhi, MA, Associate Editor
A recent study published in Dermatology and Therapy presented the results of a 3-year study, showcasing how certolizumab pegol (CZP) has positively influenced the quality of life for patients with plaque psoriasis. These findings are...
A recent study published in Dermatology and Therapy presented the results of a 3-year study, showcasing how certolizumab pegol (CZP) has positively influenced the quality of life for patients with plaque psoriasis. These findings are...
A recent study published in...
10/12/2023
Dermatology
psoriasis
News
Computational Model Illuminates Certolizumab Pegol's Impact in Psoriasis Treatment
10/12/2023
Riya Gandhi, MA, Associate Editor
In a recent study published in the Frontiers in Immunology, researchers utilized quantitative systems pharmacology (QSP) to model the effects of certolizumab pegol (CZP) within a virtual population (vPop) consisting of individuals with...
In a recent study published in the Frontiers in Immunology, researchers utilized quantitative systems pharmacology (QSP) to model the effects of certolizumab pegol (CZP) within a virtual population (vPop) consisting of individuals with...
In a recent study published in...
10/12/2023
Dermatology
psoriasis
News
Risk-Sharing Agreement Approach to Certolizumab Pegol in Psoriasis Treatment
10/11/2023
Riya Gandhi, MA, Associate Editor
Effective treatment for moderate to severe plaque psoriasis (PsO) is a critical medical need. Certolizumab pegol (CZP), a novel therapeutic option, has shown promise. A retrospective observational study published in Farmacia Hospitalaria...
Effective treatment for moderate to severe plaque psoriasis (PsO) is a critical medical need. Certolizumab pegol (CZP), a novel therapeutic option, has shown promise. A retrospective observational study published in Farmacia Hospitalaria...
Effective treatment for moderate...
10/11/2023
Dermatology
psoriasis
News
Bimekizumab Efficacy in Biologic-Naive Patients With Psoriatic Arthritis
10/11/2023
Riya Gandhi, MA, Associate Editor
In a recent study researchers have examined the efficacy and safety of bimekizumab, a monoclonal antibody that selectively inhibits IL-17A and IL-17F, in patients with active psoriatic arthritis who have not previously undergone biologic...
In a recent study researchers have examined the efficacy and safety of bimekizumab, a monoclonal antibody that selectively inhibits IL-17A and IL-17F, in patients with active psoriatic arthritis who have not previously undergone biologic...
In a recent study researchers...
10/11/2023
Dermatology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
WoundCon
November 8
ECS
November 8 ⁠–⁠ November 10
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use